Intracellular signaling by the second messenger Ca2+ through its receptor calmodulin (CaM) regulates cell function via the activation of CaM-dependent enzymes. Previous studies have shown that cell cycle progression at G1/S and G2/M is sensitive to intracellular CaM levels. However, little is known about the CaM-regulated enzymes involved. Protein phosphorylation has been shown to be important for cell-cycle regulation. Because CaM regulates several protein kinases, and at least one protein phosphatase, our studies are focusing on the roles of these enzymes within the cell cycle. As an initial approach to this problem, cDNAs encoding either normal or mutant calcium/calmodulin kinase II (CaMKII) have been expressed in Schizosaccharomyces pombe. The results show that overexpression of a constitutively active mutant CaMKII caused cell-cycle arrest in G2. Arrest was associated with a failure to activate the p34/cdc2 protein kinase. Expression of the mutant CaMKII in strains of S. pombe with altered timing of mitosis revealed that this effect is not mediated either by cdc25+ or weel+, suggesting that CaMKII may regulate G2/M progression by another mechanism.
INTRODUCTION
The Ca2" receptor protein calmodulin (CaM) is an important regulator of intracellular signaling in eukaryotic cells. Several studies suggest that Ca2" and CaM are involved in controlling the G2/M transition in eukaryotic cells (Lu and Means, 1993) . Increased Ca21 levels are associated with nuclear envelope breakdown and chromatin condensation (Poenie et al., 1985; Twigg et al., 1988) . We and others have shown that CaM is essential for cell-cycle progression at multiple points in the cell cycle including G2/M (Davis et al., 1986; Takeda and Yamamoto, 1987; Rasmussen and Means, 1989; Rasmussen et al., 1990) . Calmodulin antagonist drugs or the expression of CaM antisense RNA block progression from G2 into M-phase (Sasaki and Hidaka, 1981; Rasmussen and Means, 1989) . However, little is known about the molecular basis for this requirement or the specifc biochemical pathways regulated by CaM- dependent enzymes.
Protein phosphorylation/dephosphorylation is important in the control of cell-cycle progression. Because CaM is known to regulate several different protein kinases and at least one protein phosphatase (Means, 1988) , it is possible that the role for CaM and CaMregulated enzymes in cell-cycle regulation involves modulation of the phosphorylation state of key cell cycle regulatory proteins. Consistent with this prediction, previous studies have suggested that the multifunctional CaM-dependent protein kinase II (CaMKII) is required for the G2/M transition. Monoclonal antibodies directed against the 50 kDa a-CaMKII isoform blocked nuclear envelope breakdown in sea urchin eggs, as did a peptide encompassing the autoinhibitory domain of this enzyme (Baitinger et al., 1990) . However, the role of CaMKII is not as straightforward as suggested by these earlier studies, because expression of a truncated version of CaMKII encompassing the catalytic domain caused transient cell-cycle arrest in mouse C127 cells (PlanasSilva and Means, 1992) . However, this result must be interpreted carefully, because the expressed enzyme lacked the regulatory and multimerization domains present in the native enzyme. Consequently, the block C) 1994 by The American Society for Cell Biology to cell-cycle progression could have been because of alterations in either the substrate specificity or subcellular localization of the truncated enzyme, as compared to normal CaMKII.
The central regulator of G2/M progression is the p34/ cdc2 protein kinase (Doree, 1990; Nurse, 1990) . p34/ cdc2 activity is regulated by it's phosphorylation state. Phosphorylation of Tyr-15 is inhibitory while dephosphorylation activates the kinase (Gould and Nurse, 1989) . Two competing pathways control p34/cdc2 activity Nurse, 1986, 1987a,b) . The product of the cdc25 gene is a protein phosphatase Gautier et al., 1991; Kumagai and Dunphy, 1991; Lee et al., 1992 ) that dephosphorylates , whereas the products of the mikl and weel genes are the Tyr-15 kinases (Featherstone and Russell, 1991; Lundgren et al., 1991) . The activity of weel and mikl are in turn regulated by at least one additional kinase, niml (also called cdrl), whose role is to inhibit weel/mikl (Parker et al., 1993; Wu and Russell, 1993) .
Recent studies suggest ways in which CaMKII could be involved in G2/M progression. This could either be via modification of cdc25 phosphatase activity (Patel et al., 1992;  Gabrielli, Piwnica-Worms, Rasmussen, unpublished data) or by activation of the NIMA protein kinase, a gene first identified in Aspergillus nidulans (Lu et al., 1993b) . NIMA is a mitotic inducer that functions parallel to, and in concert with, p34/cdc2 to control G2/ M progression in A. nidulans. Temperature-sensitive mutations in NIMA block cells in G2 even though p34/ cdc2 is dephosphorylated and Hi kinase activity increases (Osmani et al., 1991) . Although CaM appears to be required for NIMA activation, the effect is indirect and the enzyme that is immediately responsible for the activation of NIMA is unknown (Lu et al., 1993b) . Finally, it has been shown that a truncated CaMKII can release Xenopus oocytes from metaphase II arrest, apparently by inducing the degradation of cyclin, with the concomitant inactivation of p34/cdc2 histone Hi kinase activity (Lorca et al., 1993) . Together, these studies point to an important role for CaMKII in G2/M control.
Because previous studies have used truncated versions of CaMKII or been performed in model systems where genetic analysis is not possible, it has been difficult to assess the role of CaMKII relative to known biochemical pathways that regulate cell proliferation.
The goal of this study was to examine the effect of expressing either normal or mutant forms of CaMKII in the fission yeast Schizosaccharomyces pombe as an approach to understanding the role of this enzyme in cellcycle control. The mutant form has a single amino acid change (T286 to D286) previously shown to produce an enzyme independent of CaM and constitutively active but that retains the functional domains of the native enzyme (Waldmann et al., 1990) . The results of this study indicate that overexpression of normal CaMKII has no effect on cell growth and division rates in exponentially growing cells. In contrast, expression of the mutant CaMKII resulted in a G2 arrest. Arrest was also associated with a failure to activate p34/cdc2 histone Hi kinase activity, and p34/cdc2 was maintained in a tyrosine-phosphorylated state. Expression of CaMKII in cdc2 mutants that have altered responses to either the cdc25+ or weel+ proteins also caused cell cycle arrest, suggesting that the constitutively active CaMKII does not act through either cdc25+ or weel+ or directly to regulate p34/cdc2. These studies suggest that another pathway functions to delay mitosis in S. pombe in response to increased CaMKII activity.
MATERIALS AND METHODS Strains and Media
The S. pombe strains used in these studies are listed in Table 1 . All strains were grown in standard minimal medium (Moreno et al., 1991) .
Uracil and adenine were added at 75 Mg/ml, leucine at 250 Ag/ml.
Thiamine-HCl (Sigma, St. Louis, MO) was prepared in Milli-Q water as a 1 mM stock, sterile-filtered, and added to growth medium at a final concentration of 2 MAM. All cultures were grown at 25°C.
CaMKII Constructs
A cDNA encoding the 50-kDa isoform of mouse CaMKII was used to construct the expression plasmids used in this study (Hanley et al., 1989 ). An Nde I site was placed at the initiator Met codon by polymerase chain reaction (PCR). Target plasmid DNA containing the CaMKII cDNA (1 j,g) and 1 yg of each of 5'-GCCCAGTGCCCA-TATGGCTACCATC-3' and the pUC/M13 forward primer were added to a reaction containing 10 mM tris(hydroxymethyl)aminomethane (Tris)-HCl pH 8.3, 50 mM KCl, 1.5 mM MgCl2, 0.01% gelatin, and 2 U Taq DNA polymerase (Perkin Elmer-Cetus, Norwalk, CT). Twenty cycles of 94°C for 1 min, 55°C for 2 min, 72°C for 3 min were carried out in a Perkin-Elmer Model 480 thermocycler, and the resulting 1.5-kilobase (kb) fragment purified on low melting temperature agarose followed by extraction from agarose using a Promega Biotech DNA Clean-up kit (Madison, WI). The ends of the PCR product were phosphorylated with T4 kinase (Promega) and filled with Klenow DNA polymerase (Promega). The fragment was then subcloned into Sma I-digested pSelect-1 (Promega). The autophosphorylation site at Thr-286 was mutated to Asp-286 by site-directed mutagenesis using the "Altered Sites" mutagenesis kit (Promega). The sequence of the mutant cDNA was confirmed using the chain termination method (Sanger et al., 1977 (Laemmli, 1970) CaM was purified by phenyl-Sepharose affinity chromatography (Means et al., 1991) and ion exchange chromatography using QSepharose Fast Flow. Purified CaM was labeled with .25I-BoltonHunter reagent as described (Means et al., 1991) , and labeled protein was separated by gel filtration on PD-10 columns (Pharmacia, Piscataway, NJ). For CaM overlay, total protein was resolved by SDS-PAGE and transferred to Immobilon-P membranes as described for Western blotting. Overlays were performed as described using 10 ng/ ml 125I-CaM (Pausch et al., 1991) .
CaM Kinase Assays
CaM kinase assays were performed as follows based on a previously described method (Planas-Silva and Means, 1992 Reactions were started by addition of the extract to the kinase buffer. Reactions were incubated for 5 min at 30°C after which 10 Al was spotted onto P-81 phosphocellulose paper, immersed into 75 mM phosphoric acid to stop the reaction, and then washed three more times for 5 min each wash in 75 mM phosphoric acid (Roskoski, 1985) . After washing filters were air dried, and activity was quantified by liquid scintillation counting. The data are expressed as pmol P04 incorporated/min/mg total protein.
Cytochemical Procedures
For staining of nuclei with 4,6-diamidino-2-phenylindole (DAPI), the procedure of Moreno et al. (1991) was used. Photographs were taken with a Zeiss Axiophot (Thornwood, NY) equipped for epifluorescence. All photographs were printed at the same final magnification.
p34/cdc2 Histone Hi Kinase Assays
Histone Hi kinase assays were performed as described (Ducommon and Beach, 1990) . Protein extracts were made from S. pombe cells by breakage with glass beads in extraction buffer (25 mM Tris-HCl pH 8.0, 10mM MgCl2, 15 mM EGTA, 0.1% Triton X-100, 0.1 mM PMSF, 1 g/iml leupeptin, 10 Mg/ml soybean trypsin inhibitor, 1 Mg/ml aprotinin, 10 Mg/ml L-1-tosylamide-2-phenylethylchloromethyl, 0.1 mM NaF, 60 mM f-glycerophosphate, 15 mM p-nitrophenylphosphate, 0.1 mM Na-orthovanadate). p13/sucl was purified from bacterial extracts expressing the S. pombe p13 cDNA as previously described (Brizuela et al., 1987) and were quantified by spotting 10 MAl of the reaction on Whatman (Clifton, NJ) 3MM paper followed by trichloroacetic acid (TCA) precipitation and washing as described (Ducommon and Beach, 1990 ).
Activity was quantified by liquid scintillation counting of the TCAprecipitated sample. Nonspecific background was measured using wells not coated with p13, but otherwise treated identically, and was subtracted from each sample. All determinations were done in trplicate and standard errors calculated.
p34/cdc2 Tyrosine Phosphorylation
Total protein extracts (200 Mg) were incubated in p13-Sepharosecoated microtiter plates as described above for p34/cdc2 assays. After incubation, the wells were washed four times with TBS + 0.1% Triton X-100, bound protein was solubilized by the addition of SDS-PAGE sample buffer, and the microtiter plate was incubated in a boiling water bath for 5 min. Proteins were electrophoresed and transferred to Immobilon-P filters as described above, and p34/cdc2 phosphotyrosine content was determined immunologically using an anti-P- Vol. 5, July 1994 C. Rasmussen and G. Rasmussen Tyr monoclonal antibody (UBI). The antibody was localized using the ECL procedure (Amersham) as described above.
RESULTS
Calmodulin kinase II isoforms have three major functional domains, the catalytic, regulatory, and multimerization domains (Schulman and Hanson, 1993) . The enzyme exists in vivo as a dodecamer of -600 kDa molecular weight with multimerization dependent on the C-terminal region. The regulatory region consists of overlapping substrate inhibitory and CaM-binding domains (Payne et al., 1988) . Upon binding Ca2+/CaM, CaMKII autophosphorylates at several residues including threonine-286, which lies amino-terminal to the substrate inhibitory domain (Hanson et al., 1989) . This autophosphorylation renders the kinase active and independent of CaM. Mutation of threonine-286 to aspartic acid (D286) has been shown to produce an enzyme with constitutive kinase activity 35% of the level induced by CaM activation of the normal enzyme. In contrast, normal CaMKII activity in the absence of CaM is <1% of the stimulated activity (Waldmann et al., 1990 Ca2+-CaM (Waldmann et al., 1990) .
Normal (CaMKII-T286) or mutant (CaMKII-D286) cDNAs were ligated in the nmt promoter-containing expression plasmid pREP4.1 (Figure 1) , and the resulting plasmids were transformed into S. pombe. In the presence of thiamine, expression from the nmt promoter is repressed, whereas in thiamine-free medium, high levels of expression are obtained from this promoter (Maundrell, 1990 T286 was designated CK-T, whereas the strain expressing the mutant CaMKII-D286 was designated CK-D.
Calmodulin overlay, Western blot, and in vitro analysis of CaMKII activity were used to assess expression of normal and mutant CaMKII in S. pombe. CK-T and CK-D cells were grown for 24 h in medium with or without 2 AM thiamine. For overlay and Western blotting total protein was extracted, equal amounts were resolved by SDS-PAGE and transferred to Immobilon-P membrane, and the filters were probed either with 1251-CaM or a monoclonal antibody specific for the 50 kDa CaMKII isoform. The CaM overlay showed that in the absence of thiamine, a 50-kDa CaM-binding protein, the expected size for CaMKII, was expressed in both strains ( Figure 2A) . Binding of 125I-CaM to the 50-kDa protein was Ca2' dependent (unpublished observations). Endogenous S. pombe CaM-binding proteins are likely not observed as we used 1251I-labeled A. nidulans CaM that we have previously shown binds mouse CaMKII (Rasmussen et al., 1990 ) but may not bind S. pombe proteins sufficiently well to allow detection in the CaM overlay under the conditions used. However, these data demonstrate that both the normal and mutant forms of CaMKII retain the ability to bind CaM when expressed in S. pombe. Western blot analysis using a monoclonal antibody specific for murine CaMKII a confirmed that the protein is expressed in each strain ( Figure 2B) of protein are expressed in both the CK-T and CK-D strains, and that the expressed proteins appear full length.
To determine if mouse CaMKII was active in S. pombe extracts, CaMKII assays were performed. After 24 h in minimal medium with or without thiamine, protein extracts were made as described in MATERIALS AND METHODS, and CaMKII activity was assayed by phosphorylation of a peptide substrate (syntide-2). Because mouse CaMKII becomes independent of Ca2+/CaM after autophosphorylation, or in the case of the D286 mutant has constitutive activity, assays were performed both in the absence or presence of free Ca2+. The results show that a slight increase (-40%) in CaM-independent activity is observed in cells expressing the normal form of CaMKII (Figure 3, top) , likely representing the normal activation of a fraction of the mouse CaMKII present. In contrast, Ca2+/CaM-independent activity was fourfold higher in cells expressing the D286 mutant CaMKII, as compared with the activity observed in cells not expressing the kinase (Figure 3, top) . Total CaMKII levels were expressed in the two strains as indicated by the levels of CaM-stimulated activity observed in the CK-T and CK-D strains grown in the absence (inducing conditions) of thiamine (Figure 3, bottom) . CaM-independent activity in CK-D cells expressing the altered CaMKII was -17% of the total CaM-stimulated activity, similar to earlier studies (Waldmann et al., 1990) . In summary, active mouse CaMKII can be expressed in S. pombe, and the mutant form of CaMKII displays constitutive kinase activity as expected.
Cells were next examined microscopically to determine if expression of either the normal or mutant kinases had any obvious phenotypic effects on S. pombe cells. CK-T and CK-D cells were grown for 24 h ± thiamine, fixed, and then stained with the fluorescent dye DAPI. In the CK-T strain, no significant differences were observed as a consequence of expressing normal CaMKII (Figure 4, A and B) . In contrast, expression of the mutant CaMKII in the CK-D strain produced elongated cells with a single nucleus located at the midpoint of the cell (Figure 4, C and D) . These cells are phenotypically similar to cdc mutants that block cell cycle progression but allow continued growth.
To analyze the effect of CaMKII expression on cell growth and division, cells were grown in minimal medium either in the presence or absence of thiamine, and cell numbers were determined over time. As shown, expression of normal CaMKII had no effect on cell division rates in S. pombe ( Figure 5A ). In contrast, expression of the D286 mutant resulted in a blockage of cell division, consistent with the cellular phenotype we had observed ( Figure 5B ). The kinetics of arrest were consistent with the known expression kinetics of the nmt promoter (Maundrell, 1990) . Because expression of the mutant CaMKII caused cell-cycle arrest, cells were examined to determine where in the cell cycle blockage occurred. Flow cytometric analysis showed that these It has been previously shown that p34/cdc2 histone Hi kinase activity becomes elevated in late G2 before entry into M-phase, with full activation of kinase activity during M-phase (Booher et al., 1989) . Therefore, we examined histone Hi kinase activity to determine if the cell cycle arrest might be associated with a failure to activate the p34/cdc2 kinase. Using the procedure of Ducommun and Beach (1990) , p34/cdc2 histone Hi kinase activity was assayed in cells expressing both the normal and mutant forms of CaMKII (Figure 7) . The results indicate that expression of normal CaMKII had no effect on p34/cdc2 kinase activity as expected from the lack of effect on cell division. In CK-D cells arrested in G2 by expression of the mutant CaMKII, p34/cdc2 Hi kinase activity was only increased slightly (25%).
In contrast, cdc25-22 cells arrested at the restrictive temperature for 4.25 h had p34/cdc2 kinase activity twofold that of exponentially growing control cells, whereas 20 min after release from the cdc25-22 induced arrest Cell lengths were measured from the photographs in Figure 4 . Length was normalized relative to the CK-T strain grown in the presence of thiamine.
histone H1 kinase levels were sevenfold higher than control levels. This result suggests that the Ca-MKII(D286)-induced cell-cycle arrest occurs in G2 before the activation of p34/cdc2. To better characterize this G2 arrest, several approaches were taken. First, the levels and tyrosine phosphorylation of p34/cdc2 were examined in control cultures and in cells expressing either normal or mutant CaMKII. As above, total protein was extracted from control cultures and those expressing either the normal or mutant forms of CaMKII. p34/cdc2 levels were examined by Western blot. To assess tyrosine phosphorylation of p34/cdc2, total protein was added to microtiter wells coated with p13 and the p34/cdc2 allowed to bind overnight. The wells were then washed to remove unbound protein, and the p13-bound proteins were solubilized with SDS-PAGE sample buffer. The solubilized proteins were then resolved by SDS-PAGE and P-Tyr present in p34/cdc2 analyzed by Western blot using a monoclonal antibody specific for P-Tyr. As can be seen, p34/cdc2 was at similar levels in both strains under both sets of growth conditions ( Figure 8A ) and was tyrosine phosphorylated ( Figure 8B ), consistent with the histone Hi kinase assay results. These data also suggest that expression of the mutant CaMKII causes cell-cycle arrest in G2 before the point when p34/ cdc2 undergoes cdc25-dependent tyrosine dephosphorylation that leads to the activation of histone Hi kinase activity.
To address the question of whether CaMKII affects p34/cdc2 activity, the CaMKII-(D286) mutant was expressed in mutant S. pombe strains with altered timing of mitosis. Two cdc2 mutant alleles, cdc2.lw and cdc2.3w, affect the ability of either weel+ or cdc25+ to regulate p34/cdc2 (Nurse and Thuriaux, 1980; Fantes, 1981) . Each strain was transformed with the pREP4. 1-CKII(D286) plasmid, and a representative isolate was selected. The effect of expressing the mutant CaMKII on cell division was then examined. As shown, expression of the mutant CaMKII caused cell-cycle arrest in both the cdc2.lw and cdc2.3w strains ( Figure 9A ). The effect on cell proliferation was virtually indistinguishable from that observed in cells with a normal cdc2 gene. In addition, the same elongated cell phenotype was observed ( Figure 9B ). This result suggests that cell-cycle arrest induced by the mutant CaMKII is likely not mediated through either cdc25 or weel. These data suggest that CaMKII most likely inhibits G2/M progression by another pathway and not by direct regulation of p34/ cdc2 activity. Alternatively, CaMKII might act via the mikl protein kinase or another kinase that has a function redundant to that of the weel kinase (Lundgren et al., 1991) or through phosphorylation of multiple substrates, in which case a simple epistatic relationship would not be observed. The present data indicate that CaMKII does not directly regulate p34/cdc2 activity in S. pombe.
DISCUSSION
The results of this study demonstrate that expression of a mutant form of mouse CaMKII with constitutive activity in S. pombe causes cell-cycle arrest in G2. Associated with cell-cycle arrest is a failure to activate the p34/cdc2 Hi kinase activity, a process that normally Hi kinase activity found during the cell cycle (Booher et al., 1989) .
occurs late in G2 in S. pombe (Booher et al., 1989) . In contrast, expression of the normal CaM-dependent form of CaMKII had no apparent effects on exponentially growing S. pombe. These studies indicate that substrates for CaMKII exist in S. pombe that are involved in the negative regulation of cell proliferation. Previous work has implicated CaMKII as a necessary component of the biochemical mechanism that is involved in G2/M and mitotic progression, playing a positive role in cell-cycle progression at these times. Inhibition of CaMKII in sea urchin eggs either by injection of anti-CaMKII antibodies or peptide inhibitors of CaMKII prevented nuclear envelope breakdown, suggesting that CaMKII is required for the G2/M transition (Baitinger et al., 1990) . Injection of a cDNA encoding the D286 mutation into stage VI Xenopus oocytes initiated maturation as indicated by migration of the germinal vesicle but did not lead to nuclear envelope breakdown (Waldmann et al., 1990) , consistent with the negative regulatory role for CaMKII we have observed in S. pombe.
Calmodulin-dependent phosphorylation of a 62-kDa protein in sea urchin embryos has been associated with breakdown of the mitotic apparatus (Dinsmore and Sloboda, 1988) . However, the identity of the 62-kDa protein or the specific CaM-dependent protein kinase responsible for its phosphorylation are not known. In A. nidulans CaM has been shown to be required for the G2/M transition and the activation of the NIMA protein kinase (Lu et al., 1992 (Lu et al., , 1993b ), but the mechanism through which CaM affects NIMA activity has yet to be elucidated. One possibility is that CaMKII might be an upstream component of a protein kinase cascade that ultimately regulates the NIMA kinase, because NIMA appears to be activated by phosphorylation but is not directly phosphorylated by CaMKII (Lu et al., 1993a) .
In contrast to these earlier studies, overexpression of constitutively active CaMKII appears to negatively regulate progression at the G2/M boundary. In mouse C127 cells expression of a truncated form of mouse CaMKII was associated with a transient blockage of cell-cycle progression in G2 (Planas-Silva and Means, 1992) . In these studies it was not clear if this was physiologically relevant because only the N-terminal half of the kinase was expressed. Thus, potentially critical regulatory regions of the protein including the CaM-binding and multimerization domains were lacking. Because CaMKII exists in vivo as a 600-kDa dodecamer, this altered form of the kinase, which would be a 30-kDa monomer, could have markedly different substrate specificity and/or different cellular distribution as compared to native CaMKII. The results of this study show that a constitutively active mutant form of CaMKII, differing only by a single amino acid, has the same effect on cell cycle progression in yeast. Because the mutant CaMKII used in this study differed from the wild-type version of the enzyme by only a single amino acid, it is expected that the constitutive mutant would have both normal substrate specificity and subcellular localization.
The results of this study in combination with earlier work suggest that CaMKII plays both positive and negative regulatory roles at the G2/M transition of the cell cycle. Recent in vitro studies have suggested that CaMKII might play a role in the activation of the cdc25 protein phosphatase, the enzyme responsible for dephosphorylating Y15 in p34/cdc2, a step that activates the p34/cdc2 kinase before entry into M-A a cdc2 (Osmani et al., 1991) . Because S. pombe cells expressing the mutant CaMKII arrest with p34/cdc2 in a tyrosine phosphorylated state and are inactive as an Hi kinase, our data argue that this negative regulation of G2/M progression is mediated by a distinct mechanism. It is possible that CaMKII may be acting through the mikl protein kinase or that multiple substrates may be involved, in which case suppression of the growth arrest phenotype in the cdc2-1w strain would not have been observed. A potential hypothesis suggested by the results of this study is that the negative regulation of G2/M progression by constitutively active CaMKII could be part of a G2 checkpoint mechanism. Cell-cycle checkpoints ensure that mitosis only occurs when the genome is completely replicated and undamaged (Hartwell and Weinert, 1989) . It has been known for some time that CaM is required for DNA repair. Treatment of cells with CaM antagonists inhibits repair of DNA damaged by bleomycin (Chafouleas et al., 1984) . Thus, if CaMKII was involved in DNA repair, elevated CaMKII activity might be associated with the DNA repair in progress. If this were the case, constitutively elevated CaMKII levels would be expected to cause arrest at the G2 checkpoint, upstream of the p34/cdc2 activation point. Because arrest at the G2 checkpoint is associated with tyrosine phosphorylation of p34/cdc2 (Smythe and Newport, 1992) 
